Literature DB >> 26721514

Genetic screening in acquired long QT syndrome? CAUTION: proceed carefully.

Ahmad S Amin1, Arthur A M Wilde2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26721514      PMCID： PMC4914884          DOI： 10.1093/eurheartj/ehv620

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  15 in total

Review 1.  Drug induced QT prolongation and torsades de pointes.

Authors:  Yee Guan Yap; A John Camm
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

Review 2.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

3.  Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve.

Authors:  Ling Xiao; Jiening Xiao; Xiaobin Luo; Huixian Lin; Zhiguo Wang; Stanley Nattel
Journal:  Circulation       Date:  2008-08-18       Impact factor: 29.690

4.  A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes.

Authors:  Stefan Kääb; Dana C Crawford; Moritz F Sinner; Elijah R Behr; Prince J Kannankeril; Arthur A M Wilde; Connie R Bezzina; Eric Schulze-Bahr; Pascale Guicheney; Nanette H Bishopric; Robert J Myerburg; Jean-Jacques Schott; Arne Pfeufer; Britt-Maria Beckmann; Eimo Martens; Taifang Zhang; Birgit Stallmeyer; Sven Zumhagen; Isabelle Denjoy; Abdennasser Bardai; Isabelle C Van Gelder; Yalda Jamshidi; Chrysoula Dalageorgou; Vanessa Marshall; Steve Jeffery; Saad Shakir; A John Camm; Gerhard Steinbeck; Siegfried Perz; Peter Lichtner; Thomas Meitinger; Annette Peters; H-Erich Wichmann; Christiana Ingram; Yuki Bradford; Shannon Carter; Kris Norris; Marylyn D Ritchie; Alfred L George; Dan M Roden
Journal:  Circ Cardiovasc Genet       Date:  2011-11-18

Review 5.  Genetic and clinical advances in congenital long QT syndrome.

Authors:  Yuka Mizusawa; Minoru Horie; Arthur A M Wilde
Journal:  Circ J       Date:  2014-10-01       Impact factor: 2.993

6.  Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?

Authors:  Nynke Hofman; Arthur A M Wilde; Stefan Kääb; Irene M van Langen; Michael W T Tanck; Marcel M A M Mannens; Martin Hinterseer; Britt-Maria Beckmann; Hanno L Tan
Journal:  Eur Heart J       Date:  2006-11-07       Impact factor: 29.983

7.  I(Kr) channel blockade to unmask occult congenital long QT syndrome.

Authors:  Darwin Jeyaraj; Denise P Abernethy; Rupa N Natarajan; Mary M Dettmer; Maria Dikshteyn; Diana M Meredith; Kevin Patel; Raghavendra R Allareddy; Steven A Lewis; Elizabeth S Kaufman
Journal:  Heart Rhythm       Date:  2008-01       Impact factor: 6.343

8.  Low penetrance in the long-QT syndrome: clinical impact.

Authors:  S G Priori; C Napolitano; P J Schwartz
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

9.  The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome.

Authors:  G M Vincent; K W Timothy; M Leppert; M Keating
Journal:  N Engl J Med       Date:  1992-09-17       Impact factor: 91.245

Review 10.  Long QT syndrome: beyond the causal mutation.

Authors:  Ahmad S Amin; Yigal M Pinto; Arthur A M Wilde
Journal:  J Physiol       Date:  2013-06-10       Impact factor: 5.182
View more
  2 in total

1.  Frontiers in congenital heart disease: pulmonary hypertension, heart failure, and arrhythmias.

Authors:  Thomas F Lüscher
Journal:  Eur Heart J       Date:  2016-05-07       Impact factor: 29.983

Review 2.  Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?

Authors:  Luca Sala; Milena Bellin; Christine L Mummery
Journal:  Br J Pharmacol       Date:  2016-09-20       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.